Neuro-Oncology Reviews




Volume 24 Number 24
31 December 2022




Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 24, 31 December






Kunikowska J, Morgenstern A, Pełka K, Bruchertseifer F, Królicki L.
Targeted alpha therapy for glioblastoma.
Front Med (Lausanne). 2022 Dec 16, 2022;9:1085245
. doi: 10.3389/fmed.2022.1085245. PMID: 36590948. Review. ˍ




Mohanty C, Shandilya K, Deopujari CE, Gupta G, Karmarkar V, Jaggi S.
Cervicomedullary glioblastoma: A report of two cases with review of literature.
Surg Neurol Int. 2022 Dec 16;13:579
. doi: 10.25259/SNI_581_2022. PMID: 36600754. Case report, Review. ˍ




Alkazemi M, Lo YT, Hussein H, Mammi M, Saleh S, Araujo-Lama L, Mommsen S, Pisano A, Lamba N, Bunevicius A, Mekary RA.
Laser interstitial thermal therapy for the treatment of primary and metastatic brain tumors: a systematic review and meta-analysis.
World Neurosurg. 2022 Dec 19:S1878-8750(22)01784-3
. doi: 10.1016/j.wneu.2022.12.079. PMID: 36549438. Review, Meta-analysis˰ ˍ




Antonelli M, Poliani PL.
Adult type diffuse gliomas in the new 2021 WHO Classification.
Pathologica. 2022 Dec 19;114(6):397-409
. doi: 10.32074/1591-951X-823. PMID: 36534419. Review. ˍ




Barresi V, Gianno F, Marucci G.
Newly recognised Tumour Types in Glioneuronal tumours according to the 5th edition of the CNS WHO Classification.
Pathologica. 2022 Dec 19;114(6):447-454
. doi: 10.32074/1591-951X-819. PMID: 36534423. Review. ˍ




Fabbri VP, Caporalini C, Asioli S, Buccoliero A.
Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome.
Pathologica. 2022 Dec 19;114(6):410-421
. doi: 10.32074/1591-951X-828. PMID: 36534420. Review. ˍ




Mangesius J, Mangesius S, Demetz M, Uprimny C, Di Santo G, Galijasevic M, Minasch D, Gizewski ER, Ganswindt U, Virgolini I, Thomé C, Freyschlag CF, Kerschbaumer J.
A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases.
Cancers (Basel). 2022 Dec 19;14(24):6264
. doi: 10.3390/cancers14246264. PMID: 36551750. Review. ˍ




Estevez-Ordonez D, Gary S, Atchley TJ, Maleknia P, George J, Laskay NMB, Gross E, Devulapalli R, Johnston JM.
Immunotherapy for Pediatric Brain and Spine Tumors, Current State and Future Directions.
Pediatr Neurosurg. 2022 Dec 22
. doi: 10.1159/000528792. PMID: 36549282. Review. ˍ




Gianno F, Giovannoni I, Cafferata B, Diomedi-Camassei F, Minasi S, Barresi S, Buttarelli FR, Alesi V, Cardoni A, Antonelli M, Puggioni C, Colafati GS, Carai A, Vinci M, Mastronuzzi A, Miele E, Alaggio R, Giangaspero F, Rossi S.
Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification.
Pathologica. 2022 Dec 19;114(6):422-435
. doi: 10.32074/1591-951X-830. PMID: 36534421. Review. ˍ




Yoo W, Kim S, Garcia M, Mehta S, Sanai N.
Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review.
BMC Med Res Methodol. 2022 Dec 22;22(1):327. doi: 10.1186/s12874-022-01810-7
. PMID: 36550391. Review. ˍ




Brar HK, Jose J, Wu Z, Sharma M.
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery.
Pharmaceutics. 2022 Dec 24;15(1):59
. doi: 10.3390/pharmaceutics15010059. PMID: 36678688. Review. ˍ




Manoharan N, Liu KX, Mueller S, Haas-Kogan DA, Bandopadhayay P.
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.
Neoplasia. 2022 Dec 24, 2023;36:100857
. doi: 10.1016/j.neo.2022.100857. PMID: 36566593. Review. ˍ




Kulubya ES, Kercher MJ, Phillips HW, Antony R, Edwards MSB.
Advances in the Treatment of Pediatric Brain Tumors.
Children (Basel). 2022 Dec 27;10(1):62
. doi: 10.3390/children10010062. PMID: 36670613. Review. ˍ




Muthukumar S, Darden J, Crowley J, Witcher M, Kiser J.
A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review.
Int J Mol Sci. 2022 Dec 27, 2023;24(1):408
. doi: 10.3390/ijms24010408. PMID: 36613852. Review. ˍ




Di Nunno V, Franceschi E, Gatto L, Tosoni A, Bartolini S, Brandes AA.
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments.
Expert Rev Clin Pharmacol. 2022 Dec 28:1-10
. doi: 10.1080/17512433.2023.2163385. PMID: 36576307. Review˰ ˍ




Raghu ALB, Chen JA, Valdes PA, Essayed W, Claus E, Arnaout O, Smith TR, Chiocca EA, Peruzzi PP, Bernstock JD.
Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature.
Cancers (Basel). 2022 Dec 28, 2023;15(1):174
. doi: 10.3390/cancers15010174. PMID: 36612169. Review. ˍ




Shalita C, Hanzlik E, Kaplan S, Thompson EM.
Immunotherapy for the treatment of pediatric brain tumors: a narrative review.
Transl Pediatr. 2022 Dec 28;11(12):2040-2056
. doi: 10.21037/tp-22-86. PMID: 36643672. Review. ˍ




Somma T, Bove I, Vitulli F, Cappabianca P, Pessina F, Alviggi C, Santi L, Della Pepa GM, Sabatino G, Olivi A, Ius T; Neuro-Oncology committee of the SINch (Società Italiana di Neurochirurgia).
Management and treatment of brain tumors during pregnancy: an Italian survey.
J Neurooncol. 2022 Dec 29
. doi: 10.1007/s11060-022-04215-0. PMID: 36580221. Review˰ ˍ




Wang J, Xiang C, Cai Y, Mei Z, Lu Q, Liu B, Zou L.
Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis.
Arq Neuropsiquiatr. 2022 Dec 29;80(12):1254-1261
. doi: 10.1055/s-0042-1758864. PMID: 36580964. Meta-analysis. ˍ




Zhu Y, Teng Y, Xu S, Xu Y, Zhu B, Yan W, Liu J.
Eczema as a protective factor for brain cancer: a meta-analysis.
BMC Cancer. 2022 Dec 29;22(1):1360
. doi: 10.1186/s12885-022-10471-0. PMID: 36581832. Meta-analysis. ˍ




Chen K, Andrade-Barazarte H, Liang W, Zhu Q, Guo H, Li Y, Li H, Qian R.
Post-traumatic brain injury glioma: Characteristics, report of 2 cases report and literature review.
Medicine (Baltimore). 2022 Dec 30, 2022;101(52):e32477
. doi: 10.1097/MD.0000000000032477. PMID: 36596004. Case report, Review. ˍ




Panagopoulos D, Stranjalis G, Gavra M, Boviatsis E, Korfias S, Karydakis P, Themistocleous M.
The Entity of Cerebellar Mutism Syndrome: A Narrative Review Centered on the Etiology, Diagnostics, Prevention, and Therapeutic Options.
Children (Basel). 2022 Dec 30;10(1):83
. doi: 10.3390/children10010083. PMID: 36670634. Review. ˍ




Fan Y, Wang T, Lei J, Fei F, Liu J, Liu Y.
Effects of postoperative radiotherapy and docetaxel and PD-1 inhibitors on the survival and safety of glioblastoma patients: a systematic review and meta-analysis.
Ann Transl Med. 2022 Dec 31;10(24):1326
. doi: 10.21037/atm-22-2670. PMID: 36660707. Review, Meta-analysis. ˍ




Goff KM, Zheng C, Alonso-Basanta M.
Proton radiotherapy for glioma and glioblastoma.
Chin Clin Oncol. 2022 Dec 31;11(6):46
. doi: 10.21037/cco-22-92. PMID: 36632979. Review. ˍ